Section Arrow
PRTC.NASDAQ
- PureTech Health plc
Quotes are at least 15-min delayed:2024/05/16 03:55 EDT
Last
 28.51
+0.9898 (+3.60%)
Day High 
28.51 
Prev. Close
27.5202 
1-M High
29.5199 
Volume 
1.59K 
Bid
27.4
Ask
29
Day Low
28.34 
Open
28.34 
1-M Low
25.48 
Market Cap 
744.18M 
Currency USD 
P/E -- 
%Yield
10-SMA 27.58 
20-SMA 27.67 
50-SMA 26.67 
52-W High 34 
52-W Low 17.08 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.40/-6.00
Enterprise Value
762.43M
Balance Sheet
Book Value Per Share
17.16
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
750.00K
Operating Revenue Per Share
0.06
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
DNAGinkgo Bioworks Holdings0.8391-0.0237-2.75%-- 
NVAXNovavax12.9-0.58-4.30%-- 
JAGXJaguar Health0.2551-0.0198-7.20%-- 
OCGNOcugen1.96+0.26+15.29%-- 
ARQTArcutis Biotherapeutics9.24+1.11+13.65%-- 
Quotes are at least 15-min delayed:2024/05/16 03:55 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
PureTech Health PLC is a biopharma company developing medicines to modulate the adaptive human system. It is a cross-disciplinary healthcare company developing products that could improve the lives of patients. The company is focused on developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic, and immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological & neuropsychological disorders, among others. It operates in the following segments: Wholly-Owned Programs, Controlled Founded Entities, and Parent Companies & Others. The company has a robust pipeline of advanced programs that are post-human proof of concept and focused on some of society's healthcare needs.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.